United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022

Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer.

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022

Long–term Growth Projection:

  • Mammography grasp the dominant share in the United States Breast Cancer Screening Market
  • Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
  • Number of mammograpy screening population in United States will increase to more than 50 Million by 2022

Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 – 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.

Get Sample report @: https://www.futuregenicreports.com/Request-Sample/100277

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.

The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends

Key Topics Covered in the Report

  • United States Breast Cancer Cases (2010 – 2022)
  • United States Breast Cancer Mammography Screening Population (2010 – 2022)
  • United States Breast Cancer Death (2010 – 2017)
  • Market Overview: United States Breast Cancer Screening (2010 – 2022)
  • Market Share: United States Breast Cancer Screening (2010 – 2022)
  • By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
  • Reimbursement Policies of the United States Breast Cancer Screening
  • Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
  • Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
  • Key Manufacturers Analysis

Major Breast Cancer Screening Analyzed Under This Report Are:

  • Mammography
  • Breast Magnetic Resonance Imaging(MRI)
  • Breast Ultrasound

Major Companies Covered in This Report:

  • Hitachi Medical Corporation
  • Siemen Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • GE Healthcare
  • Hologic

Obtain Report Details: https://www.futuregenicreports.com/Reports/Breast-Cancer-Screening-Market

By Regional Analysis:

  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)
  • North America
  • Latin America

About Us:

Future Generic Reports is a market research and consulting organization, offering premium collection of market research reports, custom research and consulting services to corporations, no-profit organizations and government institutions across the globe. The wide range of information is presented by a team of well-trained researchers of specific sectors through exhaustive research. We deliver premier market research services that cover all industry verticals, including chemicals and material, automotive, healthcare, electronics & semiconductor, food and beverage, pharmaceuticals and technology and media.

We believe in building an eternal bond with our clients through offering them inclusive research study meeting their specific requirements. Our services are tailored specifically to our clients by proposing them the potential outcome, based on our in-depth analysis and insights for exploring the growth strategies through providing the best possible decision for quality production.


Contact Us:

Future Generic Reports

USA Offices

244, Madison Avenue

New York City, NY – 10016

United States

Toll Free +1- 844-445-2861

Email : sales@futuregenicreports.com




Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.